Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin
William Lynn(Hammersmith Hospital), J. Cohen(Centre de Nanosciences et de Nanotechnologies), Vias Markides(Guy's and St Thomas' NHS Foundation Trust), Thomas R. Rogers(Scripps Research Institute), S. Want(Hammersmith Hospital), Sandra Lacey(Hammersmith Hospital), Elaine J. Clutterbuck(Hammersmith Hospital)
Cited by 61
Related Papers
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
|Intensive Care Medicine|2020|464
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
|The Lancet Infectious Diseases|2021|450
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections
|Clinical Infectious Diseases|1997|426
Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study
|The Lancet Respiratory Medicine|2015|336